earnings
EV
NASDAQ · EVAX
Evaxion Biotech A/S
Healthcare · Biotechnology
$3.05
Down-$0.11 (-3.48%)
Updated Oct 9, 2026, 5:03 AM
SID Score
3.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 40.36M
- P/E ratio
- -11.8
- Dividend yield
- 0.00%
- 52-week range
- $2.77 – $4.75
- Volume
- 63.97K
- Avg. volume
- 1.63M
Price performance · EVAX
EVAX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
EVAX closed at $3.05 after 21 trading sessions, down 1.61% for the selected period.
- Last close
- $3.05
- Period change
- -1.61%
- Period low
- $3.03
- Period high
- $3.34
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $3.18 | $3.23 | $3.02 | $3.05 | 63.97K |
| Oct 7, 2026 | $3.16 | $3.25 | $3.11 | $3.16 | 21.75K |
| Oct 6, 2026 | $3.24 | $3.25 | $3.12 | $3.16 | 35.87K |
| Oct 5, 2026 | $3.20 | $3.24 | $3.14 | $3.15 | 38.24K |
| Oct 2, 2026 | $3.23 | $3.2751 | $3.1558 | $3.20 | 33.92K |
| Oct 1, 2026 | $3.25 | $3.29 | $3.13 | $3.18 | 38.12K |
| Sep 30, 2026 | $3.35 | $3.35 | $3.2422 | $3.28 | 18.05K |
| Sep 29, 2026 | $3.20 | $3.31 | $3.20 | $3.27 | 38.14K |
| Sep 28, 2026 | $3.34 | $3.35 | $3.19 | $3.24 | 55.69K |
| Sep 25, 2026 | $3.30 | $3.35 | $3.24 | $3.34 | 45.06K |
| Sep 24, 2026 | $3.30 | $3.35 | $3.25 | $3.26 | 36.87K |
| Sep 23, 2026 | $3.33 | $3.35 | $3.2415 | $3.2801 | 35.21K |
| Sep 22, 2026 | $3.18 | $3.31 | $3.18 | $3.27 | 32.4K |
| Sep 21, 2026 | $3.24 | $3.25 | $3.17 | $3.21 | 36.89K |
| Sep 18, 2026 | $3.22 | $3.33 | $3.16 | $3.27 | 43.34K |
| Sep 17, 2026 | $3.10 | $3.25 | $3.05 | $3.22 | 53.34K |
| Sep 16, 2026 | $3.03 | $3.24 | $3.00 | $3.03 | 73.87K |
| Sep 15, 2026 | $3.12 | $3.15 | $3.0001 | $3.04 | 11.17K |
| Sep 14, 2026 | $3.17 | $3.17 | $3.07 | $3.07 | 21.87K |
| Sep 11, 2026 | $3.17 | $3.1995 | $3.10 | $3.13 | 30.26K |
| Sep 10, 2026 | $3.29 | $3.29 | $3.05 | $3.10 | 87.19K |
Latest EVAX news
The latest Smart Investors Daily articles mentioning EVAX.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

